References
- Pawlikowski JS, Adams PD, Nelson DM. Senescence at a glance. J Cell Sci 2013; 126(Pt 18): 4061–7; PMID:23970414; http://dx.doi.org/10.1242/jcs.109728
- Liu Y, Hawkins OE, Su Y, Vilgelm AE, Sobolik T, Thu YM, Kantrow S, Splittgerber RC, Short S, Amiri KI, Ecsedy JA, Sosman JA, Kelley MC, Richmond A. Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-kappaB impairs this drug-induced senescence. EMBO Mol Med 2013; 5(1): 149–66; PMID:23180582; http://dx.doi.org/10.1002/emmm.201201378
- Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM, Lowe SW. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 2002; 109(3): 335–46; PMID:12015983; http://dx.doi.org/10.1016/S0092-8674(02)00734-1
- Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, Newman J, Reczek EE, Weissleder R, Jacks T. Restoration of p53 function leads to tumour regression in vivo. Nature 2007; 445(7128): 661–5; PMID:17251932; http://dx.doi.org/10.1038/nature05541
- Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445(7128): 656–60; PMID:17251933; http://dx.doi.org/10.1038/nature05529
- Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol 2011; 192(4): 547–56; PMID:21321098; http://dx.doi.org/10.1083/jcb.201009094
- Wang Q, Wu PC, Dong DZ, Ivanova I, Chu E, Zeliadt S, Vesselle H, Wu DY. Polyploidy road to therapy-induced cellular senescence and escape. Int J Cancer 2013; 132(7): 1505–15; PMID:22945332; http://dx.doi.org/10.1002/ijc.27810
- Vilgelm AE, Pawlikowski JS, Liu Y, Hawkins OE, Davis TA, Smith J, Weller KP, Horton LW, McClain CM, Ayers GD, et al. Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells. Cancer Res 2015; 75(1): 181–93; PMID:25398437; http://dx.doi.org/10.1158/0008-5472.CAN-14-2405
- Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, Campisi J. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 2003; 22(16): 4212–22; PMID:12912919; http://dx.doi.org/10.1093/emboj/cdg417
- Oble DA, Loewe R, Yu P, Mihm MC, Jr. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun 2009; 9: 3; PMID:19338264